Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice.

Phillip, Moshe; Nimri, Revital; Bergenstal, Richard M; Barnard-Kelly, Katharine; Danne, Thomas; Hovorka, Roman; Kovatchev, Boris P; Messer, Laurel H; Parkin, Christopher G; Ambler-Osborn, Louise; Amiel, Stephanie A; Bally, Lia; Beck, Roy W; Biester, Sarah; Biester, Torben; Blanchette, Julia E; Bosi, Emanuele; Boughton, Charlotte K; Breton, Marc D; Brown, Sue A; ... (2023). Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice. Endocrine reviews, 44(2), pp. 254-280. Oxford University Press 10.1210/endrev/bnac022

bnac022.pdf - Accepted Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (1MB) | Preview

The significant and growing global prevalence of diabetes continues to challenge people with diabetes (PwD), healthcare providers and payers. While maintaining near-normal glucose levels has been shown to prevent or delay the progression of the long-term complications of diabetes, a significant proportion of PwD are not attaining their glycemic goals. During the past six years, we have seen tremendous advances in automated insulin delivery (AID) technologies. Numerous randomized controlled trials and real-world studies have shown that the use of AID systems is safe and effective in helping PwD achieve their long-term glycemic goals while reducing hypoglycemia risk. Thus, AID systems have recently become an integral part of diabetes management. However, recommendations for using AID systems in clinical settings have been lacking. Such guided recommendations are critical for AID success and acceptance. All clinicians working with PwD need to become familiar with the available systems in order to eliminate disparities in diabetes quality of care. This report provides much-needed guidance for clinicians who are interested in utilizing AIDs and presents a comprehensive listing of the evidence payers should consider when determining eligibility criteria for AID insurance coverage.

Item Type:

Journal Article (Review Article)


04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition

UniBE Contributor:

Bally, Lia Claudia


600 Technology > 610 Medicine & health




Oxford University Press




Pubmed Import

Date Deposited:

07 Sep 2022 09:58

Last Modified:

08 Mar 2023 00:12

Publisher DOI:


PubMed ID:


Uncontrolled Keywords:

Automated Insulin Delivery Closed-Loop Consensus Recommendations Type 1 Diabetes




Actions (login required)

Edit item Edit item
Provide Feedback